Transfer

Data funnel abstract technology background

From excellence in research to medical solutions.

Our cutting-edge research forms the basis for medical innovations. Together with our partners, we are accelerating the transfer of our research to bring new ideas from the laboratories to application even faster.
In addition to implementing innovative diagnostics, medical technologies, sustainable prevention measures and personalized therapeutics, we are shaping a dialogical and interactive transfer of knowledge. In this way, we make a valuable contribution to a healthier society.

Discover how scientific insights evolve into market-ready solutions. Our commitment to technology transfer builds bridges between research and practice – enabling the sustainable implementation of innovative ideas.

To Webpage

Happy children playing outdoor in summer

We bring research into society – in a clear, transparent way and through active exchange with the public. Discover how we foster dialogue and make scientific topics accessible to everyone.

To Webpage

A dynamic web of entities and people working together to foster and advance new ideas, technologies, and solutions.

Helmholtz Munich is partnering with Deep Science Ventures (DSV) and SPRIND, Germany’s Federal Agency for Disruptive Innovation, to support the Venture Science Doctorate (VSD) – a novel doctoral program designed to train scientists to build…

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a trial in healthy volunteers, where the vaccine…

Start of the M1 Munich Medicine Alliance

The M1 Munich Medicine Alliance has officially launched, bringing together the two Munich-based Excellence Universities – Ludwig-Maximilians-Universtiät (LMU) and the Technical University of Munich (TUM) – along with their associated university…

Taconic Biosciences, a global leader in providing animal model solutions and services, entered into an exclusive license agreement with Helmholtz Munich to provide preclinical researchers with advanced CRISPR gene editing services. Through this…

Helmholtz Munich is a partner in four Clusters of Excellence selected for funding under the Excellence Strategy of the German federal and state governments. The projects, each granted a seven-year term, were announced by the German Research…

Angioplasty Procedure: Stent Deployment in a Coronary Artery

A research team from Helmholtz Munich, the Technical University of Munich (TUM) and the TUM University Hospital has developed DeepNeo, an AI-powered algorithm that automates the process of analyzing coronary stents after implantation. The tool…

The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in Nature Medicine, the expert committee outlines initial concepts for more…

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV). The aim is to protect people from a range of serious…

In 2021, a research team led by Prof. Heiko Lickert from Helmholtz Munich discovered the insulin-inhibitory receptor "Inceptor" and its role as a suppressor of the insulin signaling pathway. Now, the researchers have unlocked another, even more…

Life Science Factory Eröffnung Laborsicht

The Life Science Factory has opened its new site on the Helmholtz campus in Munich. Beginning in 2025, around 1,800 square meters of state-of-the-art laboratories and a flexible co-working space will be available for life science start-ups and…

On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.

The X-ray of the human brain closeup image

In an ongoing phase 1 clinical trial targeting malignant glioblastoma, the initial patient has received a dosage of a novel drug candidate, derived from an antibody originating at Helmholtz Munich. This innovative compound, coupled with a…

In a new collaboration, the Computational Health Center at Helmholtz Munich has teamed up with the global pharmaceutical company Pfizer. The joint initiative, spanning three years, aims to leverage Pfizer's vast knowledge and accumulated data in…

EU Project PerForM-REACT Strengthens Pandemic Preparedness Efforts

On March 11, 2024, the inauguration of the expanded safety laboratory in Augsburg marked a milestone within the EU-funded "PerForM-REACT" project, aimed at enhancing pandemic…

test vitro Hepatitis B HBV to the hand in glove on a blue background

TherVacB, a novel therapeutic vaccine to combat chronic hepatitis B, entered the first clinical trial. The vaccine was designed and developed under the leadership of Helmholtz Munich. This phase 1a clinical trial is conducted at the Division of…

Fork with measuring tape around on pink background

2023 has changed the way we treat obesity. A new class of drugs, mimicking a gut hormone called glucagon-like peptide-1 (GLP-1), is reshaping medicine and improving many people’s lives globally. GLP-1 drugs do not only induce significant weight loss,…

Innovations and transfer are specifically promoted at Helmholtz Munich.

In collaboration with Helmholtz Munich, Medigene is expanding its portfolio of costimulatory switch proteins in the field of cancer immunotherapy. By expanding the license field, these specialized proteins, initially developed by Helmholtz Munich,…

The Life Science Factory incubator initiated by Sartorius in Göttingen and the top biomedical research center Helmholtz Munich are entering into a strategic partnership to support spin-offs in the life sciences. Within this framework, the Life…

Bayerischer Medizingipfel im TranslaTUM am 17.7.2023

"M1 - Munich Medicine Alliance" established as a strategic alliance for excellence in healthcare in Munich.

The Helmholtz Pioneer Campus was officially inaugurated today under the slogan "ENGINEERING THE FUTURE OF MEDICINE". Commissioning this new state-of-the-art research facility is a significant milestone for young talents in medical research and…

Prof. Reinhard Zeidler about hope in the fight against glioblastoma, the most common and malignant form of brain tumor and how he accelerates the development of antibodies into application.

Medical concept of cancer. 3d illustration of T cells or cancer cells.

Helmholtz Munich and Medigene AG expand their partnership in order to further discover and develop T-cell immunotherapies for solid tumors. Medigene acquired from Helmholtz Munich the exclusive, worldwide rights to the CD40L-CD28 Costimulatory Switch…

Clinical trials are a milestone in the development of safe and effective drugs and therapies. An antibody developed by Helmholtz Munich is now entering a phase 1 clinical trial. Together with the radiopharmaceutical company ITM Isotope Technologies…

Matthias Tschöp, CEO of Helmholtz Munich, talks about translating scientific discoveries into clinical practice, about ambitious targets, and about ideas he acquired during his time in the USA.

The medical technology company Dermagnostix GmbH is a joint spin-off of Helmholtz Munich, the Technical University (TU) Munich and Hahn-Schickard. Its goal: to redefine molecular diagnostics in dermatology. Dermagnostix has now qualified as one of 30…

Panoramic teamwork business join hand together concept, Business team standing hands together, Volunteer charity work. People joining for cooperation success business.

Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…

A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined the blood sugar-reducing…

A clinical study confirms the success of a novel technology developed by Helmholtz Munich and the Technical University of Munich (TUM) for the evaluation of the treatment of psoriasis. With the new method, doctors can look deeper into the skin of…

Mononucleosis and Epstein-barr virus blood test sample in lab on the white background, laboratory table

The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. Scientists at Helmholtz Munich and DZIF are already working on…

159

Patent Families

Percent thereof licensed

Spin-Offs

Products

Teenagers standing in colorful outfits against back to school themed background. Memphis style

In the 2025/26 school year, the clever.gesund school competition invites students to develop and implement creative health projects at their schools. Participants can win cash prizes of up to €500. The competition not only encourages children and…

The hands-on fair “FORSCHA – Munich Science Days” (“FORSCHA – Münchner Wissenschaftstage”) was a great success, attracting many visitors to Schwanthaler Höhe in Munich. School classes and visitors of all ages were able to explore the world of science…

The medical treatment of obesity and type 2 diabetes is currently undergoing a significant transformation. Innovative drugs such as semaglutide and tirzepatide – often referred to as "weight-loss injections" – mimic the action of specific gut…

How to Harness Artificial Intelligence and Machine Learning. Dr. Steffen Schneider explains the opportunities that AI technologies like machine learning offer – especially when this know-how is taught as early as school. For example, AI can help…

AHA – The Science Communication Hub, a Bavaria-wide initiative has been launched to unite science communication activities for greater impact and make scientific knowledge more accessible to the public. As a co-founding member, Helmholtz Munich is…

More and more women are affected by diabetes during pregnancy. Whether type 1 diabetes, type 2 diabetes or gestational diabetes diagnosed during pregnancy - the diagnosis brings with it many questions and challenges. The new special podcast series…

Cellular Reprogramming Necklace by Anna Dumitriu photo credit Audrey Rose Mizzi large_QUER

In a world where scientific innovation is increasingly interconnected, the RepliFate-Artist in Residence program seeks to further unite the realms of art and science. Led by Prof. Maria-Elena Torres-Padilla at Helmholtz Munich and supported by…

On April 8, 2025, more than 330 individuals affected by lung diseases – as well as their families – participated in the online Lung Patient Forum. The event offered attendees the opportunity to submit questions directly to leading pulmonary experts,…

Girls Day 2025_Gruppenbild_KI-Erweiterung

On Girls’ Day 2025, Helmholtz Munich opens its laboratories to welcome 25 female students for an exciting day as young researchers. Three of our research institutes provide exclusive insights into their work, demonstrating how science helps us better…

Gruppenfoto auf dem Event Inspiring Careers – Insights on Female Leadership

On March 11th, Helmholtz Munich brought together successful and inspiring women from science and business for a dynamic exchange on leadership.

floor scales and tape measure on a colored background top view. Healthy lifestyle concept, healthy eating. Body weight control.

In line with World Obesity Day, the Helmholtz Munich information portal diabinfo.de now provides comprehensive new information on obesity. In addition to content on the prevalence, risk factors, causes, and diagnosis of obesity, the portal also…

To mark the International Day of Women and Girls in Science, Helmholtz Munich has opened the exhibition STEM Passion at the Helmholtz Pioneer Campus. The exhibition celebrates the achievements of outstanding female scientists and highlights the…

Diversity Audit des Stifterverbands "Vielfalt Gestalten"

Helmholtz Munich has been awarded the "Shaping Diversity" certificate by the Stifterverband. This recognition honors the research institution's commitment to embracing diversity as an opportunity and leveraging it for organizational development.

Fachtagung „clever.gesund in der Schule unterwegs“

The earlier people start practicing a healthy lifestyle, the greater the benefits. This is why children and young people in particular should be strengthened in their health literacy - this is the central goal of the clever.gesund program. After a…

Do you know how powerful your body is? Dive into this question and more at “Stem Cells, the Genies of the Body,” an interactive exhibition opening at the Deutsches Museum’s Science Communication Lab. Created by scientists from the Helmholtz Munich…

A team of diverse people doing a group photo

In recognition of World Diabetes Day on November 14, the team from the diabetes information portal diabinfo.de is participating in multiple events to promote knowledge transfer and dialogue around diabetes. Through targeted health information,…

gespräch-ärztin-01-institut-fotoshooting-nozy-andreas pfohl-220727_0134

Almost nine million people are living with type 1 diabetes worldwide. Although this disease can be a life-threatening, it often goes unnoticed and is diagnosed too late. Yet type 1 diabetes can be diagnosed early, long before symptoms appear, by a…

WBGU_Uebergabe_2024_Claudia Traidl-Hoffmann

Prof. Claudia Traidl-Hoffmann has been reappointed for a second consecutive term to the German Advisory Council on Global Change (WBGU). This reappointment underscores the crucial role of environmental medicine in scientific policy advising. Over the…

Woman with bottle of water suffering from heat stroke outdoors

The 2024 global Lancet Countdown report on climate change and health underscores that the adverse effects of the climate crisis have reached unprecedented levels worldwide – especially concerning human health. Researchers from Helmholtz Munich…

Veranstaltung im Bergson_Abnehmspritze_Matthias Tschöp_Matthias Blüher

On October 22, science and culture converged in an exciting collaboration between Helmholtz Munich and the Bergson Kunstkraftwerk. At the inaugural event of the three-part Bergson Academy series, experts from Helmholtz Munich, along with a patient,…

Every year on October 3rd, the German broadcaster WDR organizes the event "Doors Open with The Mouse." This year, 770 companies and research institutions across Germany participated, welcoming children and parents under the theme "Working Together."…

On July 20, 2024, the clever.gesund team from Helmholtz Munich, along with colleagues from the Institute of Medical Imaging and the Human Resources department, showcased their diverse range of services at the Oben Ohne Festival on Munich's…

Kinder in einem Labor machen Experimente

This summer and fall, Helmholtz Munich will participate in three major community events in Munich: the FORSCHA, the OBEN OHNE Festival, and the Maus Türöffner-Tag. These engagements highlight Helmholtz Munich’s commitment to fostering public interest…

At the third Helmholtz Munich Expert Hour at the German Bundestag on June 4, 2024, the cutting-edge research center provided information on the potential of artificial intelligence (AI) and new technologies to improve medicine in the areas of…

Fruits and vegetables arranged in the shape of a heart, representing healthy food and nutrition,

The national diabetes information portal diabinfo.de is expanding its range of information on prevention and now also provides information on diabetes-associated non-communicable diseases.

During the 2nd Helmholtz Munich Expert Hour on April 10, 2024, representatives from politics and science gathered once again to discuss pressing health issues and stay informed about the latest developments in research. The topic "When will diabetes…

Helmholtz Munich organized its first "Expert Hour" in the German Bundestag. With this new event format, Helmholtz Munich will regularly provide information on politically relevant health and research topics in the future and support work in the…

Group of people hugging each other in the park

Around two million people in Germany live with diabetes without knowing it. Most often, it's Type 2 diabetes, which develops without symptoms. Test your risk for diabetes now at diabinfo.de. In a few minutes, you will know your personal Type 2…

Hot weather. Thermometer in front of an urban scene during heatwave.

The consequences of climate change are far-reaching and profound. Extreme weather events, such as heat waves and droughts pose a severe threat to human lives and health.

["AdobeStock_OKYSdY.jpg","AdobeStock_138055306.jpeg"]

The national diabetes information portal diabinfo.de will be represented twice this year at the Diabetes Autumn Conference (Diabetes Herbsttagung) of the German Diabetes Association in cooperation with the German Society for Nutritional Medicine in…

On This Page

Technology Transfer: Turning Innovation into Application

Public Engagement: Science in Dialogue

From Lab Bench to Startup: New Doctorate Program Offers Scientists a Venture-Building Path

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

Start of the M1 Munich Medicine Alliance

License Agreement to Expand its CRISPR/Cas9 Gene Editing Services

Helmholtz Munich Partners in four Clusters of Excellence

AI-Powered Analysis of Stent Healing

Helmholtz Launches Task Force to Strengthen Prevention Research

Start-up EBViously founded

Inceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies

Life Science Factory Expands: New Innovation Hub Opens in Munich in Cooperation with Helmholtz Munich

Helmholtz Munich contributes to the National Strategy for Gene and Cell Therapies

First Patient Administered New Drug for Brain Tumor Treatment

Helmholtz Munich and Pfizer Join Forces to Advance Target Discovery and Precision Medicine through Deep Learning

Pandemic Preparedness: New High-Tech Laboratory in Augsburg

Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

Science Has Named GLP-1 Drugs the Breakthrough of the Year

Empowering Innovations: From the Idea to Impactful Products

Medigene Expands Helmholtz Munich IP Rights for its Costimulatory Switch Proteins to Additional Immune Cell Types

Life Science Factory to Open a New Location at Helmholtz Munich in 2024

Helmholtz Munich strengthens healthcare excellence in Munich through strategic alliance

The Future of Medicine: Helmholtz Munich Opens Innovation Campus

Targeted Antibody Therapy Against Brain Tumor Glioblastoma

Helmholtz Munich partners with Medigene to accelerate Tumor Therapy

Targeting Brain Tumors: New Drug Candidate in Clinical Trial

"A startup can be just as big a success as a Leibniz Prize!"

Dermagnostix receives EIC funding of 2,5 million euros

Our Partnerships for a World Without Diabetes

New Drug Candidate Developed to Treat Type 2 Diabetes

Under the Skin: Better Treatment of Psoriasis by Scanning Light and Sound

Epstein-Barr Virus: Helmholtz Munich and DZIF Are Working on a Vaccine

Start of the clever.gesund School Competition 2025/26

High Attendance at “FORSCHA”

diabinfo in Dialogue: Obesity and Diabetes – Evolving Approaches to Prevention and Treatment

Interview Steffen Schneider: Fit for AI

Helmholtz Munich Joins AHA – The Science Communication Hub

New Special Podcast Series “Diabetes and Pregnancy” on diabinfo.de

Science Through an Artistic Lens

Lung Patient Forum – A Great Success

Girls’ Day 2025: A Day as a Scientist

Inspiring Careers – Insights on Female Leadership

diabinfo.de Expands Its Information Offerings on Obesity

Exhibition "STEM Passion": Helmholtz Munich Advocates for Greater Visibility of Women in Science

Helmholtz Munich Receives "Shaping Diversity" Certificate

Helmholtz Munich and AOK Bayern are expanding the clever.gesund health program to promote health literacy for children and young people

Stem Cells, The Genies of the Body – New Exhibition at the Deutsches Museum

diabinfo.de – Engaging in World Diabetes Day 2024

World Diabetes Day on November 14: Focus On Education and Early Detection of Diabetes

Advising With Foresight: Claudia Traidl-Hoffmann Reappointed to the WBGU

Lancet Countdown 2024: Action Needed to Protect Health in the Face of Climate Change

Helmholtz Munich at Bergson Kunstkraftwerk: From Concept to Reality – The Journey of the Weight Loss Injection

Helmholtz Munich Opened Its Doors for "The Mouse"

Helmholtz Munich Inspires Youth at the Oben Ohne Festival on Munich’s Königsplatz

Experiencing Science: From Research to Community

Helmholtz Munich in the Bundestag: Artificial Intelligence and High-Tech

diabinfo.de: New information on prevention

Helmholtz Munich at the German Parliament: Breakthroughs in Common Diseases: Obesity and Diabetes

First "Expert Hour" at the German Bundestag: Data as a driver of innovation

Test your personal risk for Type 2 diabetes online

Climate Change and Human Health: Findings from the Lancet Countdown Report 2023

diabinfo.de with Multilingual Content at the ‘Diabetes Herbsttagung’ 2023